Explore essential statistical strategies for accurate protein quantification and differential expression analysis.
Based on current operating plans, and assuming full execution of the $125 million share repurchase plan, we expect our ...
Fecal microbiota transplants may enhance patients’ response to immunotherapy, but experts caution that the latest data remain proof-of-concept and far from practice-changing.
Zymeworks (NASDAQ:ZYME) executives used the company’s fourth-quarter 2025 results call to highlight updated clinical data for ...
RAPIDe-3 met the primary and all 11 secondary efficacy endpoints with high statistical significance with deucrictibant achieving onset of symptom ...
Six-year follow-up from a trial comparing surgery with TAVR in low-risk patients showed no difference in major events, but ...
Physicists are scrambling to understand why dark energy is weakening. In a surprising twist, we must now reconsider the ...
The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...
Following positive topline results from the pivotal, global Phase 3 DRAGON trial of tinlarebant in adolescents with Stargardt disease type 1 ...
Protein S deficiency represents a rare but significant hereditary thrombophilia that poses substantial risks during pregnancy ...
Last year, our most detailed map of the universe yet suggested our understanding of dark energy has been wrong for decades. The shock result is reigniting the search for a better cosmic story ...
Cancer after cardiac surgery was linked to shorter long-term survival in a retrospective study. Read more to find out more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results